PLx Pharma Inc.

PLXPNASDAQHealthcare

$0.09

+$0.00(+0.00%)

Market Cap$2534980

P/E Ratio—

52W High$3.41

52W Low$0.009

Avg Volume4.9M

Open$0.10

Beta3.92

Free Cash Flow Financials Revenue

PLx Pharma Inc. (PLXP) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

PLXP · free cash flow · updated Jun 9, 2026

Core FCF metrics

PLXP · FCF · TTM · margin & CAGR

Free cash flow was −$32.1M for FY2021 (fiscal year ending 2021-12-31), down 160.2% year-over-year The FCF margin was -391.3%.

FY2021 Free Cash Flow−$32.1M▼ -160.2% YoY

Trailing 12M (TTM)−$59.3Mtrailing 4 quarters sum

FCF Margin-391.3%−$32.1M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

PLXP · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2021Latest−$32.1M(0M)−$32.1M▼ 160.2%-391.3%

FY2020−$12.2M(0M)−$12.3M▲ +4.3%—

FY2019−$12.7M(0M)−$12.9M▼ 27.0%—

FY2018−$9.5M(1M)−$10.2M▲ +26.7%—

FY2017−$13.3M(1M)−$13.8M▲ +11.2%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

PLXP · P/FCF · FCF yield · FCF per share

PLx Pharma Inc. (PLXP) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2021 · 2021-12-31

Cash flow statement summary

PLXP · cash flow statement · operating / investing / financing

For FY2021, PLx Pharma Inc. generated −$32.1M in operating cash flow and spent 0M in capital expenditures, yielding −$32.1M in free cash flow.

Operating Activities

−$32.1M

Cash from core business operations

2021-12-31

Investing Activities

+$0.1M

CapEx, acquisitions & investments

2021-12-31

Financing Activities

+$79.0M

Buybacks, dividends & debt

2021-12-31

FCF FormulaOperating CF (−$32.1M) − |CapEx| (0M) = FCF (−$32.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

PLXP vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

PLx Pharma Inc.YOU

PLXP

−$32.1M-160.2%-391.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

PLx Pharma Inc. (PLXP) reported free cash flow of −$32.1M for FY2021 (fiscal year ending 2021-12-31), down 160.2% year-over-year. The FCF margin was -391.3%.

PLx Pharma Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 10 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

PLXP free cash flow · 8 questions

PLx Pharma Inc. free cash flow was −$32.1M for FY2021, down 160.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$59.3M.

PLXP free cash flowPLXP FCFPLXP FCF 2021PLXP free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · PLx Pharma Inc. · PLx Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026